These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 2236731)
1. The effect of calcium channel blockers on the cyclosporine dose requirement in renal transplant recipients. Howard RL; Shapiro JI; Babcock S; Chan L Ren Fail; 1990; 12(2):89-92. PubMed ID: 2236731 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic benefits of calcium channel blockers in cyclosporine-treated organ transplant recipients: blood pressure control and immunosuppression. Weir MR Am J Med; 1991 May; 90(5A):32S-36S. PubMed ID: 2039018 [TBL] [Abstract][Full Text] [Related]
3. Effect of calcium-channel blockers on cyclosporine clearance and use in renal transplant patients. Sketris IS; Methot ME; Nicol D; Belitsky P; Knox MG Ann Pharmacother; 1994 Nov; 28(11):1227-31. PubMed ID: 7849332 [TBL] [Abstract][Full Text] [Related]
4. Increased cyclosporine blood concentrations due to verapamil administration. Maggio TG; Bartels DW Drug Intell Clin Pharm; 1988 Sep; 22(9):705-7. PubMed ID: 3063481 [TBL] [Abstract][Full Text] [Related]
5. The interaction of the calcium channel blockers verapamil and nifedipine with cyclosporin A in pediatric renal transplant patients. Crocker JF; Renton KW; LeVatte TL; McLellan DH Pediatr Nephrol; 1994 Aug; 8(4):408-11. PubMed ID: 7947026 [TBL] [Abstract][Full Text] [Related]
6. The effects of calcium channel blockers on cyclosporine and its metabolites in renal transplant recipients. Tortorice KL; Heim-Duthoy KL; Awni WM; Rao KV; Kasiske BL Ther Drug Monit; 1990 Jul; 12(4):321-8. PubMed ID: 2396304 [TBL] [Abstract][Full Text] [Related]
8. Effect of nifedipine on renal allograft function and survival beyond one year. Shin GT; Cheigh JS; Riggio RR; Suthanthiran M; Stubenbord WT; Serur D; Wang JC; Rubin AL; Stenzel KH Clin Nephrol; 1997 Jan; 47(1):33-6. PubMed ID: 9021239 [TBL] [Abstract][Full Text] [Related]
9. Renal and haemodynamic effects of amlodipine and nifedipine in hypertensive renal transplant recipients. Venkat-Raman G; Feehally J; Elliott HL; Griffin P; Moore RJ; Olubodun JO; Wilkinson R Nephrol Dial Transplant; 1998 Oct; 13(10):2612-6. PubMed ID: 9794569 [TBL] [Abstract][Full Text] [Related]
10. Arterial hypertension in heart transplant recipients treated with triple-drug immunosuppressive therapy. Olivari MT; Antolick A; Ring WS J Heart Transplant; 1989; 8(1):34-9. PubMed ID: 2647929 [TBL] [Abstract][Full Text] [Related]
11. Rapid large artery remodeling following the administration and withdrawal of calcium channel blockers in spontaneously hypertensive rats. Vaja V; Ochodnicky P; Krenek P; Klimas J; Bajuszova Z; Kyselovic J Eur J Pharmacol; 2009 Oct; 619(1-3):85-91. PubMed ID: 19683522 [TBL] [Abstract][Full Text] [Related]
12. Slow channel inhibitors verapamil and nifedipine in the management of hypertension. Gould BA; Hornung RS; Mann S; Balasubramanian V; Raftery EB J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S369-73. PubMed ID: 6184570 [TBL] [Abstract][Full Text] [Related]
13. Renal hemodynamics in hypertensive renal allograft recipients: effects of calcium antagonists and ACE inhibitors. Grekas D; Dioudis C; Kalevrosoglou I; Alivanis P; Derveniotis V; Tourkantonis A Kidney Int Suppl; 1996 Jun; 55():S97-100. PubMed ID: 8743523 [TBL] [Abstract][Full Text] [Related]
14. CYP4A/CYP2C modulation of the interaction of calcium channel blockers with cyclosporine on EDHF-mediated renal vasodilations in rats. Hammoud SH; Omar AG; Eid AA; El-Mas MM Toxicol Appl Pharmacol; 2017 Nov; 334():110-119. PubMed ID: 28899749 [TBL] [Abstract][Full Text] [Related]
15. Clinical use of calcium channel blockers as ventricular unloading agents. Guazzi MD; Cipolla C; Sganzerla P; Agostoni PG; Fabbiocchi F; Pepi M Eur Heart J; 1983 Jan; 4 Suppl A():181-7. PubMed ID: 6220895 [TBL] [Abstract][Full Text] [Related]
16. Nifedipine, verapamil and cyclosporin A pharmacokinetics in children. Ogborn MR; Crocker JF; Grimm PC Pediatr Nephrol; 1989 Jul; 3(3):314-6. PubMed ID: 2702114 [TBL] [Abstract][Full Text] [Related]
17. Control of cytomegalovirus disease in renal transplant patients treated with prednisone, azathioprine and cyclosporine using intensive monitoring and decreased immunosuppression. Gómez E; de Oña M; Mélon S; Alvarez R; Laures A; Rodríguez M; Pobes A; Alvarez-Grande J Nephron; 1999; 82(3):238-45. PubMed ID: 10395996 [TBL] [Abstract][Full Text] [Related]
18. Hypertension after renal transplantation. A comparison of cyclosporine and conventional immunosuppression. Chapman JR; Marcen R; Arias M; Raine AE; Dunnill MS; Morris PJ Transplantation; 1987 Jun; 43(6):860-4. PubMed ID: 3296353 [TBL] [Abstract][Full Text] [Related]
19. T-lymphocyte subsets in renal allograft recipients treated with cyclosporine and azathioprine. Sumpio BE; Dwyer JM; Flye MW Ann Surg; 1987 Jan; 205(1):49-53. PubMed ID: 3541801 [TBL] [Abstract][Full Text] [Related]
20. Immunosuppression after heart transplantation: prednisone and cyclosporine with and without azathioprine. Casale AS; Reitz BA; Greene PS; Augustine S; Baumgartner WA J Thorac Cardiovasc Surg; 1989 Nov; 98(5 Pt 2):951-5. PubMed ID: 2811426 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]